Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
NCT00594880Phase 2Completed
- Sponsor
- The Wistar Institute
- Start
- Jan 2008
- Primary completion
- Nov 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2a in human immunodeficiency virus infection (HIV), sponsored by The Wistar Institute. Started Jan 2008; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00594880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00594880.